AI assistant
Sending…
MYRIAD GENETICS INC — Director's Dealing 2012
Nov 13, 2012
32566_dirs_2012-11-13_76523ffa-25ab-4cc5-99da-aacfc23e65ff.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2012-11-09
Reporting Person: MELDRUM PETER D (Director, President & C.E.O.)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-11-09 | Common Stock | M | 25000 | $5.89 | Acquired | 109225 | Direct |
| 2012-11-09 | Common Stock | S | 25000 | $29.7117 | Disposed | 84225 | Direct |
| 2012-11-12 | Common Stock | M | 25000 | $5.89 | Acquired | 109225 | Direct |
| 2012-11-12 | Common Stock | S | 25000 | $29.9135 | Disposed | 84225 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-11-09 | Non-Qualified Stock Option (right to buy) | $5.89 | M | 25000 | Disposed | 2014-09-08 | Common Stock (25000) | Direct |
| 2012-11-12 | Non-Qualified Stock Option (right to buy) | $5.89 | M | 25000 | Disposed | 2014-09-08 | Common Stock (25000) | Direct |
Footnotes
F1: The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.
More from MYRIAD GENETICS INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Regulatory Filings
2026
Jun 4
Share Issue/Capital Change
2026
Jun 4
Interim / Quarterly Report
2026
May 6
Report Publication Announcement
2026
May 5
Annual Report
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Major Shareholding Notification
2026
Apr 7
Major Shareholding Notification
2026
Mar 27